The U.S. Food and Drug Administration is putting a halt to the sale of alleged treatments for COVID-19 due to concerns about the safety risks these products could have to the public.

Biogen instructed company staff to work from home following additional employees testing positive for the coronavirus. According to reports, 15 employees who attended a management meeting in Boston tested positive for the virus.

Three employees of Boston-based Biogen tested positive for the novel coronavirus.

A global coalition set up to fight epidemic diseases issued a call for $2 billion to support the development of a vaccine against the new coronavirus that is causing COVID-19 infections around the world.

As Seattle and outlying areas serve as the front lines of the coronavirus outbreak in the United States, with at least 10 deaths related to COVID-19 reported in the state of Washington, Fred Hutchinson Cancer Research Center implemented a mandatory remote work policy.

Japanese drug manufacturer Takeda Pharmaceutical indicated that the company is attempting to develop a drug based on the blood of patients who recovered from COVID-19.

The World Health Organization (WHO) warned of a global shortage and price gouging for protective equipment to fight the fast-spreading coronavirus and asked companies and governments to increase production by 40 percent as the death toll from the respiratory illness mounted.

Waltham, Massachusetts-based Thermo Fisher Scientific is acquiring Qiagen N.V., based in Venlo, The Netherlands. Thermo Fisher is offering 39 euros per share in cash for a transaction total of about $11.5 billion, and is also taking on $1.4 billion of net debt.

The Trump administration secured commitments from top pharmaceutical companies to work together to develop a vaccine and treatments to fight the coronavirus.

On the same day the White House tapped Vice President Mike Pence to lead the government response to the coronavirus, the Biotechnology Innovation Organization (BIO) tapped George Scangos to head up its own response to the outbreak, which causes the COVID-19 disease.